The field of Alzheimer’s Disease (AD) is at a turning point, as disease-modifying therapies and next-generation diagnostics reshape both research and clinical care. IQVIA’s webinar brought together leading voices to discuss what these innovations mean for clinical practice and how to ensure healthcare systems are ready to adapt.